Adamas pharmaceuticals inc (ADMS)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-16,648

-23,075

-27,582

-24,871

-29,658

-28,883

-33,152

-33,993

-34,971

-29,357

-23,360

-20,745

-16,028

-14,960

-14,394

-16,876

-13,828

-10,690

-14,859

-14,051

-12,202

9,731

-9,557

16,429

-6,380

30,944

-3,439

-3,353

26,769

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation

236

242

266

324

368

405

361

351

383

316

312

288

284

238

234

191

137

129

150

86

70

56

42

35

22

23

17

15

11

Stock-based compensation

1,481

2,066

4,463

2,939

3,384

3,753

4,143

4,149

3,741

3,456

3,262

3,765

2,884

2,789

2,598

2,631

2,553

2,751

2,623

2,440

2,142

2,296

2,037

1,823

1,047

254

132

134

120

Accretion of interest expense

3,624

3,640

3,876

3,797

3,731

3,768

5,386

5,112

4,826

2,239

1,677

729

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of embedded derivative liability

-341

-518

-138

-48

-101

-840

2

-20

-24

-237

531

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in preferred stock warrant value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

319

664

3,453

430

323

320

Net accretion of discounts and amortization of premiums of available-for-sale securities

107

222

322

338

337

344

357

291

53

-240

-287

294

-223

-31

739

-149

-258

-25

-1,459

415

194

-

-

-

-

-

-

-

-

Provision for write-down of inventory

300

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities
Accrued interest of available-for-sale securities

-218

173

-169

-110

56

-248

-60

-409

643

-100

211

14

36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

-23

234

-875

-1,087

1,987

235

1,864

1,799

1,246

364

-31

-1,655

895

25

-91

399

-823

348

575

-124

-39

404

-98

-33

122

13

-143

-615

-16

Inventory

234

400

46

610

-86

-1,686

3,233

1,168

558

1,571

75

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

105

-

-24

-76

114

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-33

-607

-334

-272

-347

1,984

-1,927

5,150

-171

2,392

374

313

-1,043

-4,968

1,098

498

729

4,023

-259

790

-138

-696

327

475

275

-444

461

-244

147

Operating lease right-of-use assets

-344

-327

-268

-215

-198

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-3,298

-

-

-

3,319

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

817

-83

3,944

-

415

982

-473

-2,505

1,482

1,468

57

46

-653

-183

2

585

325

2,663

-2,052

776

-2,109

398

-222

Current portion of long-term debt

-2,042

-1,742

-1,587

-1,457

-1,664

-1,316

-994

-248

-60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of operating lease liabilities

401

397

309

248

234

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-29,611

Accrued liabilities and other liabilities

-1,172

30

-251

-586

1,485

183

3,551

107

-357

2,869

3,184

1,263

-938

-290

-1,757

994

-1,668

-351

1,964

1,901

-4,334

8,923

374

126

311

716

-27

25

-191

Net cash used in operating activities

-17,313

-18,313

-18,659

-22,890

-20,917

-23,605

-23,235

-32,584

-24,799

-24,824

-15,383

-12,684

-13,936

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,928

-12,009

-12,502

-

-10,826

-9,982

-14,065

-

-6,928

20,953

-6,785

36,573

-5,206

-1,631

-2,935

Cash flows from investing activities
Purchases of property and equipment

0

0

0

11

7

-613

1,180

-5

502

322

315

257

364

402

-22

783

461

268

684

429

18

1,091

0

117

77

5

12

104

46

Purchases of available-for-sale securities

33,962

37,224

17,988

17,846

20,811

15,569

989

4,900

178,896

5,986

16,453

33,079

6,992

8,000

95,528

0

0

27,250

14,143

0

18,435

-

-

-

-

-

-

-

-

Maturities of available-for-sale securities

31,000

49,000

45,750

44,000

44,000

38,000

40,520

24,760

28,800

29,083

19,150

23,300

17,800

31,648

9,142

21,581

16,072

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-2,962

11,776

27,762

26,143

23,182

23,044

38,351

19,865

-150,598

22,775

2,382

-10,036

10,444

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-86,364

20,798

15,611

-

8,833

9,656

-18,453

-

0

-117

-77

-5

-12

-104

-46

Cash flows from financing activities
Proceeds from public offerings, net of offering costs

-

-

-

-

-

0

0

-165

134,433

0

0

0

0

0

0

-208

62,030

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock upon exercise of stock options

42

12

133

99

66

6

1,046

1,703

590

5,918

1,991

526

675

48

796

1,959

163

-

34

337

300

-

0

214

36

-4

18

4

3

Principal payments on convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,720

860

1,420

Proceeds from issuance of common and preferred stock upon exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

429

544

1,013

-

-

-

-

Net cash provided by financing activities

42

338

133

548

66

400

1,046

2,381

135,023

71,244

1,504

35,420

675

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-20,233

-6,199

9,236

3,801

2,331

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-40,374

-

-11,497

12,700

-2,817

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

796

2,077

62,193

-

1,184

9,025

300

-

-153

43,972

1,049

-4

-1,702

-856

-1,417

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-99,496

10,866

65,302

-

-809

8,699

-32,218

-

-7,081

64,808

-5,813

36,564

-6,920

-2,591

-4,398

Supplemental disclosure of noncash activities
Right-of-use assets obtained in exchange for operating lease liabilities

0

160

891

439

7,566

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment in accounts payable and accrued expense

0

0

0

-10

10

-471

468

-96

106

10

0

0

51

-79

-40

-133

400

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation capitalized in inventory

108

74

74

34

26

33

47

73

49

26

13

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock option exercise settled after period end

-

-

-

-

-

-

-

71

169

-

-

0

0

-

-

-

208

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment acquired through tenant improvement allowance

-

-

-

-

-

-

-

73

163

-337

337

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability assumed in noncash stock transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-235

-1,364

1,940

-

-

-

-